Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pinto Joshua
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ho Maykin
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Piacquad David
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Halawa Alaa
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fust Matthew K
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Burow Kristina
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Aurora Daljit Singh
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pinto Joshua
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BERNS PAUL L
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Aurora Daljit Singh
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Suh Carol Y.
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lenz Robert A.
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Milligan Michael Lee
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gosebruch Henry O
Neumora Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Paul L Berns(5.2%)
Neumora Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-SoftBank Group Corp.(5.0%),SB Global Advisers Limited(5.0%), etc.
Neumora Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARCH Venture Fund VII, L.P.(20.9%),ARCH Venture Fund VIII Overage, L.P.(20.9%), etc.
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner ARCH Venture Partners XII, LLC
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner ARCH Venture Partners X, LLC
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Burow Kristina
No Data